RxSight, Inc. RXST
4.90 USD +0.04 (+0.82%)
At closeNov 10, 2026, 4:00 PM EST
5.00 +0.10 +2.04%
After hours · Nov 10, 4:00 PM ET
4.74 Day range 5.12
4.11 52-week range 13.22
- YTD
- -52.98%
- 1 year
- -51.53%
News
benzinga.com Piper Sandler Maintains Neutral on RxSight, Lowers Price Target to $8 Piper Sandler analyst Adam Maeder maintains RxSight (NASDAQ:RXST) with a Neutral and lowers the price target from $10 to $8.
benzinga.com Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $6 Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lowers the price target from $9 to $6.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by…
benzinga.com Needham Maintains Buy on RxSight, Lowers Price Target to $7 Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $11 to $7.
benzinga.com RxSight Q3 2026 Earnings Call Transcript RxSight (NASDAQ:RXST) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com RxSight Q3 Adj. EPS $(0.21) Beats $(0.29) Estimate, Sales $24.586M Miss $27.137M Estimate RxSight (NASDAQ:RXST) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.29) by 27.59 percent. This is a 425 percent decrease over losses of $(0.04) per…